Key Takeaways Fresenius Medical shares gained 13.3% YTD while the industry declined 11.5%.Fresenius Medical expanded its global network with acquisitions and partnerships.Q2 earnings and revenues beat estimates, aided by pricing momentum and cost savings.Fresenius Medical Care AG & Co. (FMS) is well-positioned for growth, backed by strategic acquisitions and partnerships, as well as a solid global foothold. However, rising costs remain a concern.Shares of this Zacks Rank #3 (Hold) company have risen 13.3% y ...